• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CARDINAL HEALTH MAGELL INSULIN 3/10ML 29GX1/2; SYRINGE, PISTON

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CARDINAL HEALTH MAGELL INSULIN 3/10ML 29GX1/2; SYRINGE, PISTON Back to Search Results
Model Number 8881892930
Device Problem Fail-Safe Did Not Operate (4046)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/12/2022
Event Type  malfunction  
Manufacturer Narrative
An investigation is currently underway.Upon completion, the results will be forwarded.
 
Event Description
The customer reported that they were unable to get the safety lock to engage.The primary nurse brought it to the pcm for demo and after multiple attempts, was unable to get the lock to engage.The needle bent as well while attempting to place the orange cap back on the syringe.No injuries occurred.
 
Manufacturer Narrative
A device history record (dhr) review of the reported lot number confirmed that the product was produced accomplishing quality requirements and released according to established procedures.The manufacturing site received 3 samples for evaluation.Two of the syringe samples received were unpackaged and one of the syringe samples was packaged.A complete investigation was performed.Visual inspection to the quality inspection standard (qis) was conducted.Visual inspection of the unpackaged syringe samples identified bent cannula and the safety lock was locked, therefore the shield appears to have functioned as required.Shield/collar lock and shield/collar spin testing was performed on the one packaged syringe sample and the device passed the specifications.The cannula was not bent on this sample.The safety shield functioned as expected.Based on the examination of the samples and the description provided by the customer it is likely a failure of the user to follow the instructions for use (ifu).There are two opportunities for the user to not follow the ifu and could report a failure of the safety shield.First, the user is required to extend the safety shield forward until they feel a positive stop and hear an audible snap to secure the shield for safe transportation to the patient site.Had the user not extended to an audible snap, they may think the shield is not functioning properly.Second, after use of the syringe the user is to extend the shield fully forward until a click is heard and twist the shield until they feel a positive stop and hear an audible snap.Had the user not twisted the shield as instructed, the shield would appear to not function as intended.During the assembly of this product, inspectors routinely test samples for visual problem, shield retract force, shield extend force, shield-locking torque, shield/collar spin force, and detach force.The test results are reviewed for each shop order prior to release to verify that all testing during production was acceptable and within specification limits.The product cannot be accepted unless the acceptable quality level has been met.The following control mechanisms are in place to prevent the occurrence and acceptance of safety shield issues by the syringe assembly process.The molding process is validated, and the critical dimensions of the molded components are gauged to ensure molded components meet dimensional specifications.Preventive maintenance of the molding tool is conducted at required frequencies, in order to ensure process capability is maintained.Procedures and work instructions exist for the proper handling and verification of components and the operation of the syringe assembly machines.Personnel are trained and certified in the operation of the molding, assembly and packaging equipment, product evaluation and documentation requirements.The criteria are not met for a formal investigation, at this time.Complaint trends are evaluated during the monthly corrective and preventative action (capa) meeting to determine if a capa is warranted.At this time, a capa will not be initiated.This complaint will be used for tracking and trending purposes.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MAGELL INSULIN 3/10ML 29GX1/2
Type of Device
SYRINGE, PISTON
Manufacturer (Section D)
CARDINAL HEALTH
1222 sherwood rd
norfolk NE 68701
Manufacturer (Section G)
CARDINAL HEALTH
1222 sherwood rd
norfolk NE 68701
Manufacturer Contact
jill saraiva
777 west street
mansfield, MA 02048
5086183640
MDR Report Key13537085
MDR Text Key289749071
Report Number1915484-2022-01273
Device Sequence Number1
Product Code FMF
UDI-Device Identifier30884521006632
UDI-Public30884521006632
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type User Facility,Company Representative
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 03/23/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/15/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Model Number8881892930
Device Catalogue Number8881892930
Device Lot Number032161X
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? No
Date Manufacturer Received01/24/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage A
Patient Sequence Number1
-
-